Table 1 The clinical and laboratory characteristics of T2DM patients with (Plaque group) and without carotid plaque (Non-plaque group)

n

418

531

Male, n (%)

57.42%

67.23%

Hypertension, n (%)

167(167/418)

367(367/531)

DN,n(%)

140(140/418)

229(229/531)

Age, years

52.05 ± 12.15

62.32 ± 9.53

BMI, kg/m²

25.49 ± 3.78

25.07 ± 3.75

WHR

0.92 ± 0.07

0.95 ± 0.06

Duration of diabetes, years

6(1,10)

11(5,19)

HOMA-IR

4.23 ± 1.76

4.88 ± 1.09

TC, mmol/L

4.70 ± 1.20

4.85 ± 1.30

TG, mmol/L

1.96 ± 0.79

1.83 ± 1.26

LDL-C, mmol/L

2.85 ± 1.03

2.95 ± 1.09

HDL-C, mmol/L

1.22 ± 0.61

1.20 ± 0.31

HDL-C/LDL-C

0.48 ± 0.26

0.46 ± 0.24

Residual cholesterol, mmol/L

0.53(0.34,0.84)

0.58(0.38,0.86)

Lip(a),mg/L

118.16 ± 42.73

145.81 ± 60.97

FBG,mmol/L

8.70 ± 3.31

8.67 ± 3.54

PPG,mmol/L

15.74 ± 3.90

16.60 ± 5.74

Uric acid, umol/L

327.45 ± 94.94

344.22 ± 94.85

eGFR, ml/min per 1.73m²

109.01 ± 53.20

95.14 ± 29.22

F-CP,ug/L

1.95 ± 0.91

1.99 ± 1.13

2 h-CP,ug/L

4.23 ± 2.11

4.30 ± 1.84

F-ins,mIU/L

7.10(4.10,11.95)

7.70(4.10,14.15)

2 h-ins,mIU/L

31.22 ± 10.46

31.67 ± 12.43

HbA1c,%

9.35 ± 2.79

9.34 ± 2.23

CEA,ng/ml

2.35(1.63,3.37)

2.85(1.95,4.23)

CA199,U/ml

8.51(4.31,17.05)

9.45(4.96,9.45)